Delivery Order SPE2DB20D1004-SPE2DB25FNEPF

Award Date 1/29/25
Potential Completion Date 1/30/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,555.93 firm fixed-price delivery order is for the supply of Clobazam 10 mg tablets in packs of 100. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,555.93 firm fixed-price delivery order is for the supply of 4,567,154,080 units of Clobazam 10 mg tablets. The award has an ultimate completion date of February 5, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,555.93 firm fixed-price delivery order is for the supply of 4,567,117,521 units of the drug Clobazam 10 mg tablet. The award has an ultimate completion date of February 3, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,667.79 firm fixed-price delivery order is for the supply of 4,567,039,867 units of the drug Clobazam 10 mg tablets. The contract has an ultimate completion date of January 27, 2025 and was awarded on January 24, 2025. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,176,880 units of the drug clobazam 10 mg tablets. The $1,555.93 firm fixed price contract has a completion date of July 18, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, valued at $1,874.81, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The award, which does not have a set-aside designation, is a firm fixed price delivery order for 4,563,867,997 units of the medication Clobazam 10 mg Tablet. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,666.40 firm fixed-price delivery order is for the supply of 4,566,435,764 units of the pharmaceutical drug Clobazam 10 mg tablets. The award has an ultimate completion date of November 15, 2024 and was not set aside for any specific business type. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,624.57 firm fixed-price delivery order is for the supply of 100 tablets of the medication Clobazam 10 mg. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,104,148 units of the prescription drug clobazam 10 mg tablets. The delivery order has a ceiling value of $3,644.89 and an ultimate completion date of October 16, 2024. The contract is a firm fixed-price Delivery Order, and there was no set-aside designation used. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,111.86, is for the delivery of Clobazam 10 mg tablets to support federal medical programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB25FNEPF
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,568.35 firm fixed-price delivery order is for the supply of 4,567,086,308 units of the medication clobazam 10 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award demonstrates AmerisourceBergen's significant role as a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems.

Generated 4/30/25, 9:50 AM